Christopher Duma, Oleg Kopyov, Alex Kopyov, Mark Berman, Elliot Lander, Michael Elam, Michael Arata, David Weiland, Ruslana Cannell, Chad Caraway, Sean Berman, Kristin Scord, Lian Stemler, Karlyssa Chung, Samuel Khoudari, Rory McRory, Chace Duma, Sawyer Farmer, Anthony Bravo, Christian Yassa, Ami Sanathara, Elisa Singh, Benjamin Rapaport
We have chosen to test the safety of human intracerebroventricular (ICV) brain injections of autologous non-genetically-modified adipose-derived stromal vascular fraction (ADSVF). In this IRB-approved trial, 24 patients received ICV ADSVF via an implanted reservoir between 5/22/14 and 5/22/17. Seven others were injected via their ventriculo-peritoneal shunts. Ten patients had Alzheimer's disease (AD), 6 had amyotrophic lateral sclerosis (ALS), 6 had progressive multiple sclerosis (MS-P), 6 had Parkinson's "Plus" (PD+), 1 had spinal cord injury, 1 had traumatic brain injury, and 1 had stroke...
October 2019: Molecular Biology Reports